<div id="readability-page-1"><p>Alerus Financial NA trimmed its position in shares of  Marsh &amp; McLennan Companies, Inc. (NYSE:MMC - Free Report) by 9.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor  owned 16,669 shares of the financial services provider's stock after selling 1,684 shares during the period. Alerus Financial NA's holdings in Marsh &amp; McLennan Companies were worth $3,541,000 as of its most recent filing with the Securities and Exchange Commission.</p><ul><li>Technical Analysis: Four Stocks That Could Move Through Resistance</li></ul><p>Other institutional investors have also recently bought and sold shares of the company. Modera Wealth Management LLC lifted its holdings in shares of  Marsh &amp; McLennan Companies by 2.5% during the 4th quarter. Modera Wealth Management LLC now owns 1,885 shares of the financial services provider's stock valued at $400,000 after buying an additional 46 shares during the last quarter.  Geneos Wealth Management Inc. lifted its position in shares of  Marsh &amp; McLennan Companies by 3.7% in the fourth quarter. Geneos Wealth Management Inc. now owns 1,324 shares of the financial services provider's stock worth $281,000 after buying an additional 47 shares during the last quarter.  Hemington Wealth Management boosted its stake in shares of  Marsh &amp; McLennan Companies by 6.7% during the 4th quarter. Hemington Wealth Management now owns 768 shares of the financial services provider's stock worth $163,000 after acquiring an additional 48 shares in the last quarter.  New England Professional Planning Group Inc. raised its stake in shares of  Marsh &amp; McLennan Companies by 4.1% in the 4th quarter. New England Professional Planning Group Inc. now owns 1,261 shares of the financial services provider's stock valued at $268,000 after acquiring an additional 50 shares in the last quarter.  Finally, TFB Advisors LLC lifted its holdings in  Marsh &amp; McLennan Companies by 2.0% in the 4th quarter. TFB Advisors LLC now owns 2,576 shares of the financial services provider's stock worth $547,000 after purchasing an additional 51 shares during the last quarter. Institutional investors and hedge funds own  87.99% of the company's stock. </p><h2>Marsh &amp; McLennan Companies Price Performance</h2><p>Shares of MMC opened at $243.77 on Friday. The company has a debt-to-equity ratio of 1.44, a quick ratio of 1.13 and a current ratio of 1.13. Marsh &amp; McLennan Companies, Inc. has a 52-week low of $196.17 and a 52-week high of $243.89. The stock has a 50 day simple moving average of $229.10 and a 200 day simple moving average of $224.08. The firm has a market capitalization of $119.72 billion, a PE ratio of 29.76, a P/E/G ratio of 2.70 and a beta of 0.95. </p><p>Marsh &amp; McLennan Companies (NYSE:MMC - Get Free Report) last issued its quarterly earnings results on Thursday, January 30th. The financial services provider reported $1.87 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.12. Marsh &amp; McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%.  Sell-side analysts predict that  Marsh &amp; McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year. </p><h2>Marsh &amp; McLennan Companies Dividend Announcement</h2><p>The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 3rd will be paid a $0.815 dividend. The ex-dividend date is Thursday, April 3rd. This represents a $3.26 annualized dividend and a yield of 1.34%. Marsh &amp; McLennan Companies's dividend payout ratio (DPR) is presently 39.80%. </p><h2>Analysts Set New Price Targets</h2><p>A number of analysts have recently weighed in on the stock. JPMorgan Chase &amp; Co. boosted their price objective on shares of Marsh &amp; McLennan Companies from $230.00 to $235.00 and gave the stock a &#34;neutral&#34; rating in a research note on Friday, January 3rd. Raymond James  reaffirmed an &#34;outperform&#34; rating and issued a $250.00 price target (up from $240.00) on shares of Marsh &amp; McLennan Companies in a research report on Thursday, February 6th. Redburn Atlantic assumed coverage on Marsh &amp; McLennan Companies in a research report on Tuesday. They set a &#34;buy&#34; rating and a $281.00 price objective for the company. Royal Bank of Canada raised Marsh &amp; McLennan Companies from a &#34;sector perform&#34; rating to an &#34;outperform&#34; rating and raised their target price for the company from $242.00 to $250.00 in a report on Thursday, December 12th. Finally, Keefe, Bruyette &amp; Woods cut their price target on Marsh &amp; McLennan Companies from $214.00 to $210.00 and set an &#34;underperform&#34; rating for the company in a report on Monday, February 3rd. Two analysts have rated the stock with a sell rating, ten have assigned  a hold rating and five have assigned  a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and an average price target of $233.41.</p><p><b>Check Out Our Latest Report on MMC</b></p><h2>Insider Activity at Marsh &amp; McLennan Companies</h2><p>In other news, CEO Dean Michael Klisura sold 7,121 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $234.97, for a total transaction of $1,673,221.37. Following the completion of the sale, the chief executive officer now directly owns 20,935 shares in the company, valued at $4,919,096.95. This represents a 25.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Nicholas Mark Studer sold 49,390 shares of the company's stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $230.16, for a total value of $11,367,602.40. Following the sale, the chief executive officer now owns 28,329 shares in the company, valued at approximately $6,520,202.64. The trade was a 63.55 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 57,828 shares of company stock worth $13,350,279. Corporate insiders own  0.30% of the company's stock. </p><h2>Marsh &amp; McLennan Companies Company Profile</h2> (Free Report)<p>Marsh &amp; McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Marsh &amp; McLennan Companies</li><li>Energy and Oil Stocks Explained</li><li>Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell </li><li>Most active stocks: Dollar volume vs share volume</li><li>Top 3 Beverage Stocks Pouring Out Profits</li><li>How to Calculate Return on Investment (ROI)</li><li>CarMax and Carvana: Steering the Used Car Market</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Marsh &amp; McLennan Companies Right Now?</h2><p>Before you consider Marsh &amp; McLennan Companies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh &amp; McLennan Companies wasn't on the list.</p><p>While Marsh &amp; McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MRSH

<p>Alerus Financial NA reduced its stake in Marsh & McLennan Companies, Inc. (NYSE:MMC) by 9.2% in Q4, now holding 16,669 shares valued at $3.54 million. Other institutional investors also adjusted their positions. Marsh & McLennan's stock opened at $243.77, with a market cap of $119.72 billion and a PE ratio of 29.76. The company recently declared a quarterly dividend of $0.815, with a yield of 1.34%. Analysts have set new price targets, with JPMorgan raising theirs to $235 and Raymond James to $250.</p>

Alerus Financial NA Has $3.54 Million Position in Marsh & McLennan Companies, Inc. (NYSE:MMC)